[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Blend Labs, Inc. (BLND) shows a proposed sale of 17,500 common shares via Charles Schwab & Co., Inc. with an aggregate market value of $70,063.00, to be sold on 09/05/2025 on the NYSE. The shares were acquired through restricted stock lapse events on 03/20/2024 (3,597 shares) and 05/20/2024 (13,903 shares) as equity compensation from Blend Labs, Inc. The filer also reported six prior sales by the same person between 07/03/2025 and 09/04/2025, totaling 28,000 shares and gross proceeds of $99,028.00. The notice includes the filer’s statement that they are not aware of undisclosed material adverse information.

Positive

• None.

Negative

• Proposed insider sale of 17,500 common shares reported for 09/05/2025
• Recent open-market sales by the same person: six transactions from 07/03/2025 to 09/04/2025 totaling 28,000 shares

Insights

Securities Analyst

TL;DR: Insider plans to sell newly vested equity totaling 17,500 shares; prior open-market sales occurred recently.

The filing documents a proposed open-market sale of 17,500 common shares through Charles Schwab on 09/05/2025, with those shares originating from restricted stock lapses in March and May 2024 as equity compensation. The filing also discloses six prior transactions by the same person between July and September 2025 totaling 28,000 shares. From a securities-transaction perspective, these are routine disclosures of insider sales under Rule 144 rather than corporate operational developments. The submission includes the standard attestation regarding absence of undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Documented insider sales and vesting events raise governance transparency but show no indication of material company events.

The Form 144 provides transparency about equity compensation lapses and subsequent proposed and completed sales by an insider. It notes the use of a broker and lists aggregate market values and gross proceeds for past sales. The filing meets disclosure requirements for insider dispositions; however, it contains no statements about corporate actions, litigation, or financial results. As such, the filing is a governance disclosure without material impact on company fundamentals.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	17500	70063.00	255696747	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/20/2024	Restricted Stock Lapse	BLEND LABS, INC.			3597	03/20/2024	Equity Compensation
Common	05/20/2024	Restricted Stock Lapse	BLEND LABS, INC.			13903	05/20/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/03/2025	8000	28000.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/10/2025	4000	14160.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/24/2025	4000	14360.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/07/2025	4000	14477.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/22/2025	4000	14000.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	09/04/2025	4000	14031.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for BLND disclose about the proposed transaction?

The form discloses a proposed sale of 17,500 common shares via Charles Schwab on 09/05/2025 with an aggregate market value of $70,063.00 on the NYSE.

How were the shares to be sold acquired according to the filing?

The shares were acquired via restricted stock lapse events from Blend Labs, Inc. on 03/20/2024 (3,597 shares) and 05/20/2024 (13,903 shares) as equity compensation.

Has the filer sold other BLND shares recently?

Yes; the filing lists six sales between 07/03/2025 and 09/04/2025 totaling 28,000 shares with gross proceeds of $99,028.00.

Which broker is handling the proposed sale?

The proposed sale is through Charles Schwab & Co., Inc. located at 3000 Schwab Way, Westlake, TX 76262.

Does the filing indicate any undisclosed adverse information about Blend Labs?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.